Methyl-CpG binding protein 2 gene (MECP2) variations in Japanese patients with Rett syndrome: Pathological mutations and polymorphisms

Takayuki Fukuda, Yushiro Yamashita, Shinichiro Nagamitsu, Kenichi Miyamoto, Jing Ji Jin, Iori Ohmori, Yoko Ohtsuka, Katsuko Kuwajima, Shoichi Endo, Tsuyako Iwai, Hidehisa Yamagata, Yasuharu Tabara, Tetsuro Miki, Toyojiro Matsuishi, Ikuko Kondo

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

A total of 45 different mutations of methyl-CpG-binding protein 2 gene (MECP2) were identified in 145 of 219 Japanese patients with typical or atypical Rett syndrome (RTT) (66.2%). A missense mutation, T158M was the most common mutation of MECP2, identified in 22 (19.1%) patients, followed by four nonsense mutations, R168X (14.8%), R270X (13.0%), R255X (9.6%), and R294X (6.1%) in 115 patients with classical RTT. Two missense mutations, R133C (33.3%) and R306C (23.3%), and a nonsense mutation, R294X (13.3%), were common in 30 patients with atypical RTT, including the preserved speech variant (PSV). Frameshift mutations due to nucleotide deletion or insertion were identified in 22 patients with MECP2 mutations, and one of them had a 3.6 kb deletion encompassing exons 3 and 4. Three patients with classical RTT had a splicing anomaly. The wide spectrum of phenotypic variability in patients with RTT has been considered to be correlated with the mutation type and location in MECP2, and X-inactivation. However, most patients showed a random X-inactivation pattern evaluated by an androgen receptor gene polymorphism in this study, suggesting that a skewed X-inactivation might not be a main modification factor on clinical phenotypes of RTT. In addition, three new missense mutations, P176R, A378V and T479M, were identified in patients with RTT, but also in healthy Japanese, indicating that these mutations are non-pathogenic in Japanese. Information about rare polymorphic variations is very important for the molecular diagnosis of RTT, although rare polymorphic variants might differ among ethnic groups.

Original languageEnglish
Pages (from-to)211-217
Number of pages7
JournalBrain and Development
Volume27
Issue number3 SPEC. ISS.
DOIs
Publication statusPublished - Apr 2005

Fingerprint

Methyl-CpG-Binding Protein 2
Rett Syndrome
Mutation
Genes
X Chromosome Inactivation
Missense Mutation
Nonsense Codon
Frameshift Mutation
Androgen Receptors
Gene Silencing
Ethnic Groups
Exons
Nucleotides

Keywords

  • Methyl-CpG-binding protein 2 gene (MECP2)
  • Rett syndrome (RTT)
  • Single nucleotide polymorphism (SNP)
  • X-inactivation

ASJC Scopus subject areas

  • Clinical Neurology
  • Pediatrics, Perinatology, and Child Health
  • Neurology

Cite this

Methyl-CpG binding protein 2 gene (MECP2) variations in Japanese patients with Rett syndrome : Pathological mutations and polymorphisms. / Fukuda, Takayuki; Yamashita, Yushiro; Nagamitsu, Shinichiro; Miyamoto, Kenichi; Jin, Jing Ji; Ohmori, Iori; Ohtsuka, Yoko; Kuwajima, Katsuko; Endo, Shoichi; Iwai, Tsuyako; Yamagata, Hidehisa; Tabara, Yasuharu; Miki, Tetsuro; Matsuishi, Toyojiro; Kondo, Ikuko.

In: Brain and Development, Vol. 27, No. 3 SPEC. ISS., 04.2005, p. 211-217.

Research output: Contribution to journalArticle

Fukuda, T, Yamashita, Y, Nagamitsu, S, Miyamoto, K, Jin, JJ, Ohmori, I, Ohtsuka, Y, Kuwajima, K, Endo, S, Iwai, T, Yamagata, H, Tabara, Y, Miki, T, Matsuishi, T & Kondo, I 2005, 'Methyl-CpG binding protein 2 gene (MECP2) variations in Japanese patients with Rett syndrome: Pathological mutations and polymorphisms', Brain and Development, vol. 27, no. 3 SPEC. ISS., pp. 211-217. https://doi.org/10.1016/j.braindev.2004.06.003
Fukuda, Takayuki ; Yamashita, Yushiro ; Nagamitsu, Shinichiro ; Miyamoto, Kenichi ; Jin, Jing Ji ; Ohmori, Iori ; Ohtsuka, Yoko ; Kuwajima, Katsuko ; Endo, Shoichi ; Iwai, Tsuyako ; Yamagata, Hidehisa ; Tabara, Yasuharu ; Miki, Tetsuro ; Matsuishi, Toyojiro ; Kondo, Ikuko. / Methyl-CpG binding protein 2 gene (MECP2) variations in Japanese patients with Rett syndrome : Pathological mutations and polymorphisms. In: Brain and Development. 2005 ; Vol. 27, No. 3 SPEC. ISS. pp. 211-217.
@article{79819c6358714b3088f15a513657ad0c,
title = "Methyl-CpG binding protein 2 gene (MECP2) variations in Japanese patients with Rett syndrome: Pathological mutations and polymorphisms",
abstract = "A total of 45 different mutations of methyl-CpG-binding protein 2 gene (MECP2) were identified in 145 of 219 Japanese patients with typical or atypical Rett syndrome (RTT) (66.2{\%}). A missense mutation, T158M was the most common mutation of MECP2, identified in 22 (19.1{\%}) patients, followed by four nonsense mutations, R168X (14.8{\%}), R270X (13.0{\%}), R255X (9.6{\%}), and R294X (6.1{\%}) in 115 patients with classical RTT. Two missense mutations, R133C (33.3{\%}) and R306C (23.3{\%}), and a nonsense mutation, R294X (13.3{\%}), were common in 30 patients with atypical RTT, including the preserved speech variant (PSV). Frameshift mutations due to nucleotide deletion or insertion were identified in 22 patients with MECP2 mutations, and one of them had a 3.6 kb deletion encompassing exons 3 and 4. Three patients with classical RTT had a splicing anomaly. The wide spectrum of phenotypic variability in patients with RTT has been considered to be correlated with the mutation type and location in MECP2, and X-inactivation. However, most patients showed a random X-inactivation pattern evaluated by an androgen receptor gene polymorphism in this study, suggesting that a skewed X-inactivation might not be a main modification factor on clinical phenotypes of RTT. In addition, three new missense mutations, P176R, A378V and T479M, were identified in patients with RTT, but also in healthy Japanese, indicating that these mutations are non-pathogenic in Japanese. Information about rare polymorphic variations is very important for the molecular diagnosis of RTT, although rare polymorphic variants might differ among ethnic groups.",
keywords = "Methyl-CpG-binding protein 2 gene (MECP2), Rett syndrome (RTT), Single nucleotide polymorphism (SNP), X-inactivation",
author = "Takayuki Fukuda and Yushiro Yamashita and Shinichiro Nagamitsu and Kenichi Miyamoto and Jin, {Jing Ji} and Iori Ohmori and Yoko Ohtsuka and Katsuko Kuwajima and Shoichi Endo and Tsuyako Iwai and Hidehisa Yamagata and Yasuharu Tabara and Tetsuro Miki and Toyojiro Matsuishi and Ikuko Kondo",
year = "2005",
month = "4",
doi = "10.1016/j.braindev.2004.06.003",
language = "English",
volume = "27",
pages = "211--217",
journal = "Brain and Development",
issn = "0387-7604",
publisher = "Elsevier",
number = "3 SPEC. ISS.",

}

TY - JOUR

T1 - Methyl-CpG binding protein 2 gene (MECP2) variations in Japanese patients with Rett syndrome

T2 - Pathological mutations and polymorphisms

AU - Fukuda, Takayuki

AU - Yamashita, Yushiro

AU - Nagamitsu, Shinichiro

AU - Miyamoto, Kenichi

AU - Jin, Jing Ji

AU - Ohmori, Iori

AU - Ohtsuka, Yoko

AU - Kuwajima, Katsuko

AU - Endo, Shoichi

AU - Iwai, Tsuyako

AU - Yamagata, Hidehisa

AU - Tabara, Yasuharu

AU - Miki, Tetsuro

AU - Matsuishi, Toyojiro

AU - Kondo, Ikuko

PY - 2005/4

Y1 - 2005/4

N2 - A total of 45 different mutations of methyl-CpG-binding protein 2 gene (MECP2) were identified in 145 of 219 Japanese patients with typical or atypical Rett syndrome (RTT) (66.2%). A missense mutation, T158M was the most common mutation of MECP2, identified in 22 (19.1%) patients, followed by four nonsense mutations, R168X (14.8%), R270X (13.0%), R255X (9.6%), and R294X (6.1%) in 115 patients with classical RTT. Two missense mutations, R133C (33.3%) and R306C (23.3%), and a nonsense mutation, R294X (13.3%), were common in 30 patients with atypical RTT, including the preserved speech variant (PSV). Frameshift mutations due to nucleotide deletion or insertion were identified in 22 patients with MECP2 mutations, and one of them had a 3.6 kb deletion encompassing exons 3 and 4. Three patients with classical RTT had a splicing anomaly. The wide spectrum of phenotypic variability in patients with RTT has been considered to be correlated with the mutation type and location in MECP2, and X-inactivation. However, most patients showed a random X-inactivation pattern evaluated by an androgen receptor gene polymorphism in this study, suggesting that a skewed X-inactivation might not be a main modification factor on clinical phenotypes of RTT. In addition, three new missense mutations, P176R, A378V and T479M, were identified in patients with RTT, but also in healthy Japanese, indicating that these mutations are non-pathogenic in Japanese. Information about rare polymorphic variations is very important for the molecular diagnosis of RTT, although rare polymorphic variants might differ among ethnic groups.

AB - A total of 45 different mutations of methyl-CpG-binding protein 2 gene (MECP2) were identified in 145 of 219 Japanese patients with typical or atypical Rett syndrome (RTT) (66.2%). A missense mutation, T158M was the most common mutation of MECP2, identified in 22 (19.1%) patients, followed by four nonsense mutations, R168X (14.8%), R270X (13.0%), R255X (9.6%), and R294X (6.1%) in 115 patients with classical RTT. Two missense mutations, R133C (33.3%) and R306C (23.3%), and a nonsense mutation, R294X (13.3%), were common in 30 patients with atypical RTT, including the preserved speech variant (PSV). Frameshift mutations due to nucleotide deletion or insertion were identified in 22 patients with MECP2 mutations, and one of them had a 3.6 kb deletion encompassing exons 3 and 4. Three patients with classical RTT had a splicing anomaly. The wide spectrum of phenotypic variability in patients with RTT has been considered to be correlated with the mutation type and location in MECP2, and X-inactivation. However, most patients showed a random X-inactivation pattern evaluated by an androgen receptor gene polymorphism in this study, suggesting that a skewed X-inactivation might not be a main modification factor on clinical phenotypes of RTT. In addition, three new missense mutations, P176R, A378V and T479M, were identified in patients with RTT, but also in healthy Japanese, indicating that these mutations are non-pathogenic in Japanese. Information about rare polymorphic variations is very important for the molecular diagnosis of RTT, although rare polymorphic variants might differ among ethnic groups.

KW - Methyl-CpG-binding protein 2 gene (MECP2)

KW - Rett syndrome (RTT)

KW - Single nucleotide polymorphism (SNP)

KW - X-inactivation

UR - http://www.scopus.com/inward/record.url?scp=20044386658&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20044386658&partnerID=8YFLogxK

U2 - 10.1016/j.braindev.2004.06.003

DO - 10.1016/j.braindev.2004.06.003

M3 - Article

C2 - 15737703

AN - SCOPUS:20044386658

VL - 27

SP - 211

EP - 217

JO - Brain and Development

JF - Brain and Development

SN - 0387-7604

IS - 3 SPEC. ISS.

ER -